According to the economic impact study, the total economic impact of the dietary supplement industry in 2023 was $158.6 billion.
The Council for Responsible Nutrition (CRN; Washington, D.C.) has released its updated economic impact study, which is a comprehensive analysis of the dietary supplement industry’s contribution to the U.S. economy. According to CRN’s press release, the economic impact study is important to its advocacy efforts because it help the association quantify and communicate the financial importance dietary supplement companies have within legislative districts. This helps inform the decisions of Congressional leaders as they consider how legislation impacts businesses in their districts.
According to the economic impact study, the total economic impact of the dietary supplement industry in 2023 was $158.6 billion. This is an increase of 23% or $121.6 billion from the association previous report published in 2016. This includes a direct economic impact of $74.2 billion, an indirect economic impact of $39.5 billion, and an induced economic impact of $44.9 billion. The tax revenue from industry in 2023 was $20 billion, and the wages earned by employees working directly for supplement companies was over $19 billion. Total wages earned from those employed indirectly or through induced jobs was nearly $45 billion.
“In the eight years since our last report, the industry’s footprint and subsequent impact to the local, state and national economies has increased dramatically and we believe it is important for the public and elected officials to know the positive contributions our member companies have on communities all over the country,” said CRN President and CEO Steve Mister, in a press release. “In some suburban or rural areas, they are among the largest employers and taxpayers, if not the largest, and provide needed jobs and revenue. This report helps us clearly quantify that impact in specific and tangible terms.”
The top ten states with the largest dietary supplement industry presence are:
The data was compiled by the consulting firm John Durham and Associates.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.